Cite Filings / CMPX / 0000950170-22-008244

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Compass Therapeutics, Inc. Filed 2022-05-09 Acc 0000950170-22-008244

Documents 1

10-Q Quarterly Report , cmpx-20220331.htm

Around this filing

2022-08-01 10-Q Quarterly Report
2022-05-13 4 Director bought 192,516 shares at an average $2.18 ($420,482)
2022-05-10 4 CHIEF EXECUTIVE OFFICER bought 27,836 shares at $1.80 ($50,105)
2022-05-10 4 Director bought 125,359 shares at an average $1.57 ($197,252)
2022-05-10 4 Director bought 125,359 shares at an average $1.57 ($197,252)
2022-05-09 10-Q Quarterly Report
2021-11-12 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading cmpx-20220331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…